Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
216
NCT04909450
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 24, 2021
Completion: Jun 4, 2024
NCT06257355
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
Phase: Phase 1
Start: Feb 5, 2024
Completion: Jan 31, 2026
NCT06452316
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
Start: May 15, 2024
Completion: May 31, 2026